Skip to main content
Top
Published in: Acta Neuropathologica 3/2018

01-03-2018 | Correspondence

Multinodular and vacuolating neuronal tumor of the cerebrum is a clonal neoplasm defined by genetic alterations that activate the MAP kinase signaling pathway

Authors: Melike Pekmezci, Meredith Stevers, Joanna J. Phillips, Jessica Van Ziffle, Boris C. Bastian, Nadejda M. Tsankova, Bette K. Kleinschmidt-DeMasters, Marc K. Rosenblum, Tarik Tihan, Arie Perry, David A. Solomon

Published in: Acta Neuropathologica | Issue 3/2018

Login to get access

Excerpt

Initially described in 2013, multinodular and vacuolating neuronal tumor of the cerebrum (MVNT) is a low-grade neuronal neoplasm of the cerebral hemispheres composed of small to medium sized neuronal cells arranged in nodules involving the deep cortex and subcortical white matter, showing prominent intracytoplasmic and stromal vacuolation [8]. The tumor cells are typically immunopositive with some glial and neuronal markers (OLIG2 and synaptophysin), but negative for others (GFAP and NeuN), and are associated with ramified CD34-positive processes in adjacent parenchyma. The radiologic features of MVNT are distinct and include predominantly solid, T2-hyperintense lesions in the deep cortical ribbon and superficial white matter with variable internal nodularity and typically absent contrast enhancement [1, 8, 11]. Patients may be asymptomatic or can present with seizures or headaches, and all pathologically proven cases have reportedly followed a benign clinical course to date [1, 8, 11]. The molecular basis of MVNT is unknown, and some authors have suggested that MVNT is a malformative lesion rather than a true clonal neoplasm [4, 13]. …
Appendix
Available only for authorised users
Literature
1.
go back to reference Alsufayan R, Alcaide-Leon P, de Tilly LN, Mandell DM, Krings T (2017) Natural history of lesions with the MR imaging appearance of multinodular and vacuolating neuronal tumor. Neuroradiology 59:873–883CrossRefPubMed Alsufayan R, Alcaide-Leon P, de Tilly LN, Mandell DM, Krings T (2017) Natural history of lesions with the MR imaging appearance of multinodular and vacuolating neuronal tumor. Neuroradiology 59:873–883CrossRefPubMed
2.
go back to reference Arai Y, Totoki Y, Hosoda F et al (2014) Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma. Hepatology 59:1427–1434CrossRefPubMed Arai Y, Totoki Y, Hosoda F et al (2014) Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma. Hepatology 59:1427–1434CrossRefPubMed
3.
go back to reference Brown NA, Furtado LV, Betz BL et al (2014) High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis. Blood 124:1655–1658CrossRefPubMed Brown NA, Furtado LV, Betz BL et al (2014) High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis. Blood 124:1655–1658CrossRefPubMed
4.
go back to reference Cathcart SJ, Klug JR, Helvey JT, White ML, Gard AP, McComb RD (2017) Multinodular and vacuolating neuronal tumor: a rare seizure-associated entity. Am J Surg Pathol 41:1005–1010CrossRefPubMed Cathcart SJ, Klug JR, Helvey JT, White ML, Gard AP, McComb RD (2017) Multinodular and vacuolating neuronal tumor: a rare seizure-associated entity. Am J Surg Pathol 41:1005–1010CrossRefPubMed
5.
go back to reference Chakraborty R, Burke TM, Hampton OA et al (2016) Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis. Blood 128:2533–2537CrossRefPubMedPubMedCentral Chakraborty R, Burke TM, Hampton OA et al (2016) Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis. Blood 128:2533–2537CrossRefPubMedPubMedCentral
6.
go back to reference Chakraborty R, Hampton OA, Shen X et al (2014) Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis. Blood 124:3007–3015CrossRefPubMedPubMedCentral Chakraborty R, Hampton OA, Shen X et al (2014) Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis. Blood 124:3007–3015CrossRefPubMedPubMedCentral
7.
go back to reference Dahlman KB, Xia J, Hutchinson K et al (2012) BRAF(L597) mutations in melanoma are associated with sensitivity to MEK inhibitors. Cancer Discov 2:791–797CrossRefPubMedPubMedCentral Dahlman KB, Xia J, Hutchinson K et al (2012) BRAF(L597) mutations in melanoma are associated with sensitivity to MEK inhibitors. Cancer Discov 2:791–797CrossRefPubMedPubMedCentral
8.
go back to reference Huse JT, Edgar M, Halliday J, Mikolaenko I, Lavi E, Rosenblum MK (2013) Multinodular and vacuolating neuronal tumors of the cerebrum: 10 cases of a distinctive seizure-associated lesion. Brain Pathol 23:515–524CrossRefPubMed Huse JT, Edgar M, Halliday J, Mikolaenko I, Lavi E, Rosenblum MK (2013) Multinodular and vacuolating neuronal tumors of the cerebrum: 10 cases of a distinctive seizure-associated lesion. Brain Pathol 23:515–524CrossRefPubMed
9.
go back to reference Huse JT, Snuderl M, Jones DT et al (2017) Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway. Acta Neuropathol 133:417–429CrossRefPubMed Huse JT, Snuderl M, Jones DT et al (2017) Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway. Acta Neuropathol 133:417–429CrossRefPubMed
10.
go back to reference Kline CN, Joseph NM, Grenert JP et al (2017) Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy. Neuro-Oncol 19:699–709PubMed Kline CN, Joseph NM, Grenert JP et al (2017) Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy. Neuro-Oncol 19:699–709PubMed
11.
go back to reference Nunes RH, Hsu CC, da Rocha AJ et al (2017) Multinodular and vacuolating neuronal tumor of the cerebrum: a new “leave me alone” lesion with a characteristic imaging pattern. Am J Neuroradiol 38:1899–1904CrossRefPubMed Nunes RH, Hsu CC, da Rocha AJ et al (2017) Multinodular and vacuolating neuronal tumor of the cerebrum: a new “leave me alone” lesion with a characteristic imaging pattern. Am J Neuroradiol 38:1899–1904CrossRefPubMed
Metadata
Title
Multinodular and vacuolating neuronal tumor of the cerebrum is a clonal neoplasm defined by genetic alterations that activate the MAP kinase signaling pathway
Authors
Melike Pekmezci
Meredith Stevers
Joanna J. Phillips
Jessica Van Ziffle
Boris C. Bastian
Nadejda M. Tsankova
Bette K. Kleinschmidt-DeMasters
Marc K. Rosenblum
Tarik Tihan
Arie Perry
David A. Solomon
Publication date
01-03-2018
Publisher
Springer Berlin Heidelberg
Published in
Acta Neuropathologica / Issue 3/2018
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-018-1820-4

Other articles of this Issue 3/2018

Acta Neuropathologica 3/2018 Go to the issue